Ascendis Pharma A/S Share Price & Technical Analysis
ASND · $239.8 (-2.95%)
Healthcare / Biotechnology
$239.8
-2.95%
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is al…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
8% return in May, 2% avg return in past 3 year May month.
14% return in 2026, 36% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 6% | 3% | -3% | -1% | 8% | – | – | – | – | – | – | – | 14% |
| 25 | -5% | 23% | -1% | 9% | -5% | 4% | 2% | 13% | 2% | 1% | 5% | 2% | 49% |
| 24 | 5% | 13% | 2% | -8% | -2% | 1% | -2% | 4% | 9% | -18% | 10% | 2% | 16% |
| 23 | -1% | -11% | -3% | 4% | 14% | 2% | 1% | 9% | -6% | -4% | 12% | 25% | 42% |
| 22 | -10% | -8% | 3% | -22% | -7% | 10% | -8% | 5% | 15% | 10% | 5% | -1% | -7% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Uptrend
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$14.81B
P/E ratio
26.84
52W high
$250.7
52W low
$156.6
Volume
95,506
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Ascendis Pharma A/S share price today?
- Ascendis Pharma A/S (ASND) last traded around $239.8 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ASND have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ASND. Download the app for real-time alerts.
- How can I analyze Ascendis Pharma A/S stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.